Crossmark

Individualized cognitive-behavioral therapy improves anxiety, depression, sleep quality, hopelessness, and disease severity in fibromyalgia syndrome: a single-blind randomized controlled trial

Crossref DOI link: https://doi.org/10.1007/s00296-026-06146-9

Published Online: 2026-05-26

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Kocyigit, Burhan Fatih https://orcid.org/0000-0002-6065-8002
Öztürk, Gülşah Yaşa https://orcid.org/0000-0002-9033-5095
Sönmez, Mehmet Macit https://orcid.org/0000-0003-4584-0495
Yerkebayeva, Saltanat K. https://orcid.org/0009-0003-1234-7044
Assylbek, Meirgul I. https://orcid.org/0000-0003-0338-3281
Funding

Funding for this research was provided by:

University of Health Sciences
License Information

Text and Data Mining valid from 2026-05-26

Version of Record valid from 2026-05-26
More Information

Article History

Received: 16 April 2026

Accepted: 5 May 2026

First Online: 26 May 2026

Declarations

:

: The authors declare no conflicts of interest.

: Raw data can be shared if requested.

Document is current

Any future updates will be listed below